Results 151 to 160 of about 307,700 (302)

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T. Muanda   +2 more
wiley   +1 more source

Transient narrowing of a wide QRS tachycardia. What is the mechanism?

Journal of Arrhythmia, 2020
Francisco Ribes, Ángel Martínez‐Brótons, Ángel Ferrero‐De‐Loma‐Osorio, Lourdes Bondanza, Cristina Albiach, Víctor Marcos‐Garcés, Ricardo Ruiz‐Granell   +6 more
doaj   +1 more source

Cardiac Arrhythmias [PDF]

Postgraduate Medical Journal, 1964
openaire   +2 more sources

Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy

BMEMat, EarlyView.
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim, Hak Yong Kim, Ja Hoon Koo, Gi Doo Cha, Dae‐Hyeong Kim, Hye Jin Kim   +5 more
wiley   +1 more source

Biomaterial design strategies for enhancing mitochondrial transplantation therapy

BMEMat, EarlyView.
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang, Yushan Zhang, Hang Li, Sirui Peng, Donghao Lyu, Chunxiao Zhou, Sheng Ding, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Hongjun Wang, Deling Kong, Weiwei Wang   +12 more
wiley   +1 more source

Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Management of coronary perforation in bifurcation lesions with covered stents remains challenging. Aims We aimed to describe a proper practice and toolbox for “jailed‐branch” management after covered stent deployment. Methods Using a bench model, we tested various wires with a 120° angulated microcatheter for their ability to ...
Rayyan Hemetsberger, Anass Maaroufi, Kevin Hamzaraj, Judit Andreka, Mohammad Abdelghani, Serdar Farhan, Daniel Lootz, Johannes Gollmer, Nader Mankerious, Christian Hengstenberg, Tom W. Johnson, Gabor G. Toth   +11 more
wiley   +1 more source

Population Modeling Approach for Human Cardiac Arrhythmia Risk Prediction. [PDF]

Circ Arrhythm Electrophysiol
Song Z, Sui F, Huang X, Liu MB, Gao W, Weiss JN, Qu Z.   +6 more
europepmc   +1 more source

Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet, Siddhartha Mengi, David Garcia Labbé, Can Manh Nguyen, Jean‐Michel Paradis   +4 more
wiley   +1 more source

Postoperative Atrial Arrhythmias After Lung Transplantation: A Single Center Analysis of Risk Factors, Management, and Outcomes. [PDF]

Clin Transplant
Chen DM, Arunachalam A, Peigh G, Knight BP, Kurihara C, Subramani MV, Myers C, Betensley A, Warrior K, Bemiss BC, Kamar A, Al-Kazaz M.   +11 more
europepmc   +1 more source

Coronary Slow Flow and No‐Reflow During Percutaneous Coronary Intervention: Contemporary Insights Into Imaging‐Guided Prediction, Prevention, and Management

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Coronary slow flow (SF) and no‐reflow (NR) are clinically significant complications of percutaneous coronary intervention (PCI), particularly in ST‐segment elevation myocardial infarction (STEMI) and saphenous vein graft (SVG) interventions. Angiographically defined as impaired myocardial perfusion despite restored epicardial patency, SF/NR ...
Bharat Khialani, Eran Sim, George Touma, Sarah Fairley, Cuneyt Ada, Bernard Wong   +5 more
wiley   +1 more source